76 Biggest Movers From Yesterday
Gainers
Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share.
55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) shares jumped 128% to $12.41. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer.
Zai Lab Inks Back To Back Licensing Agreements For Cancer And Psychiatric Candidates
Zai Lab Limited (NASDAQ:ZLAB) and Blueprint Medicines Corporation (NASDAQ:BPMC) have announced an exclusive collaboration and license agreement in Greater China, including mainland China,…
Mizuho Maintains Buy on Karuna Therapeutics, Raises Price Target to $182
Mizuho analyst Vamil Divan maintains Karuna Therapeutics (NASDAQ:KRTX) with a Buy and raises the price target from $150 to $182.
Citigroup Initiates Coverage On Karuna Therapeutics with Buy Rating, Announces Price Target of $152
Citigroup analyst Neena Bitritto-Garg initiates coverage on Karuna Therapeutics (NASDAQ:KRTX) with a Buy rating and announces Price Target of $152.
Karuna Therapeutics Q2 EPS $(1.17) Down From $(0.65) YoY
Karuna Therapeutics (NASDAQ:KRTX) reported quarterly losses of $(1.17) per share. This is a 80 percent decrease over losses of $(0.65) per share from the same period last year.
RBC Capital Maintains Outperform on Karuna Therapeutics, Raises Price Target to $173
RBC Capital analyst Brian Abrahams maintains Karuna Therapeutics (NASDAQ:KRTX) with a Outperform and raises the price target from $164 to $173.
Karuna Therapeutics Announces Results From Phase 1b Trial Evaluating Safety And Tolerability Of KarXT In Healthy Elderly Volunteers; Co. To Initiate Phase 2 Trial In 2H 2022
Company to initiate a Phase 2 trial evaluating KarXT in dementia-related psychosis in the first half of 2022
Results suggest that KarXT can be administered to elderly volunteers at doses which achieve xanomeline blood
26 Biotechnology Stocks Moving In Wednesday’s After-Market Session
Gainers • Innovate, Inc. (NASDAQ:INNT) stock rose 29.2% to $0.85 during Wednesday’s after-market session. • Genprex, Inc. (NASDAQ:GNPX)…